Consensus on Molecular Testing in Lung Cancer

被引:0
|
作者
Parth Shah
Jacob Sands
机构
[1] Tufts University,Department of Medicine, Lahey Hospital and Medical Center
[2] Harvard Medical School,Dana
关键词
Non-small cell lung cancer; Molecular testing; EGFR; KRAS; Liquid biopsy; Next generation sequencing;
D O I
10.1007/s13665-018-0201-8
中图分类号
学科分类号
摘要
引用
收藏
页码:49 / 55
页数:6
相关论文
共 50 条
  • [21] Molecular testing in non-small cell lung cancer
    Mahmood, Bayan
    Yin, Su Lei
    Muhammad, SyedAun
    Dancey, Gairin
    Medeiros, Filomena
    LUNG CANCER, 2022, 165 : S35 - S35
  • [22] LungMATCH: Rates of molecular testing in the lung cancer community.
    King, Jennifer C.
    Ciupek, Andrew
    Perloff, Tara
    Blanchard, Ashley
    Mason, Kimberly
    Blais, Edik
    Bender, R. Joseph
    Halverson, David
    Madhavan, Subha
    Petricoin, Emanuel
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [23] Consensus statement on lung cancer
    Biesalski, HK
    deMesquita, BB
    Chesson, A
    Chytil, F
    Grinble, R
    Hermus, RIJ
    Kohrle, J
    Lotan, R
    Norpoth, K
    Pastorino, U
    Thurnham, D
    EUROPEAN JOURNAL OF CANCER PREVENTION, 1997, 6 (04) : 316 - 322
  • [24] Single Slide Assessment: the future of molecular testing in lung cancer?
    Diggins, Benjamin
    Glinski, Leonie
    Garvican, James
    Wijesinghe, Meme
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [25] Notable variation of molecular testing in metastatic lung cancer in the Netherlands
    Kuijpers, C.
    Van den Heuvel, M.
    Overbeek, L.
    Van Lindert, A.
    Damhuis, R.
    Willems, S.
    ANNALS OF ONCOLOGY, 2019, 30
  • [26] Clinical testing for molecular targets for personalized treatment in lung cancer
    Lam, David C. L.
    RESPIROLOGY, 2013, 18 (02) : 233 - 237
  • [27] Identifying and Addressing Gaps in Molecular Testing for Patients with Lung Cancer
    King, J.
    Ciupek, A.
    Perloff, T.
    Blanchard, A.
    Mason, K.
    Blais, E.
    Halverson, D.
    Bender, J.
    Madhavan, S.
    Petricoin, E.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1906 - S1906
  • [28] Second ESMO consensus conference on lung cancer: pathology and molecular biomarkers for non-small-cell lung cancer
    Kerr, K. M.
    Bubendorf, L.
    Edelman, M. J.
    Marchetti, A.
    Mok, T.
    Novello, S.
    O'Byrne, K.
    Stahel, R.
    Peters, S.
    Felip, E.
    ANNALS OF ONCOLOGY, 2014, 25 (09) : 1681 - 1690
  • [29] Biomarkers in Non-Small Cell Lung Cancers: Indian Consensus Guidelines for Molecular Testing
    Prabhash, Kumar
    Advani, Suresh H.
    Batra, Ullas
    Biswas, Bivas
    Chougule, Anuradha
    Ghosh, Mithua
    Muddu, Vamshi Krishna
    Sahoo, T. P.
    Vaid, Ashok K.
    ADVANCES IN THERAPY, 2019, 36 (04) : 766 - 785
  • [30] Optimising tissue acquisition and the molecular testing pathway for patients with non-small cell lung cancer: A UK expert consensus statement
    Navani, Neal
    Butler, Rachel
    Ibrahimo, Salma
    Verma, Anjali
    Evans, Matthew
    Doherty, Gary J.
    Ahmed, Samreen
    LUNG CANCER, 2022, 172 : 142 - 153